IL15 and hematopoietic and lymphoid system neoplasm: In addition, membrane-bound IL-15 expressed on NK cells (mbIL-15 NK) or IL15 gene-modified NK cells have been investigated and displayed the ability to survive and proliferate without exogenous cytokines, as well as superior cytotoxicity against both hematological neoplasms and solid tumors (56–59).